Cargando…

Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia

Amyloid plaques and tau tangles are pathological hallmarks of Alzheimer’s disease (AD). Parkinson’s disease (PD) results from the accumulation of α-synuclein. TAR DNA-binding protein (TDP-43) and total tau protein (T-Tau) play roles in FTD pathology. All of the pathological evidence was found in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiu, Pai-Yi, Yang, Fu-Chi, Chiu, Ming-Jang, Lin, Wei-Che, Lu, Cheng-Hsien, Yang, Shieh-Yueh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605966/ https://www.ncbi.nlm.nih.gov/pubmed/36289355 http://dx.doi.org/10.1038/s41598-022-22647-6

Ejemplares similares

Synergistic Association between Plasma Aβ(1–42) and p-tau in Alzheimer’s Disease but Not in Parkinson’s Disease or Frontotemporal Dementia
por: Chiu, Ming-Jang, et al.
Publicado: (2021)

Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles
por: Yang, Shieh-Yueh, et al.
Publicado: (2016)

Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
por: Lin, Chin-Hsien, et al.
Publicado: (2018)

Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
por: Lin, Chin-Hsien, et al.
Publicado: (2017)

Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
por: Wang, Pan, et al.
Publicado: (2020)

Reduced vascular risk factors in Parkinson's disease dementia and dementia with Lewy bodies compared to Alzheimer's disease
por: Chan, Po‐Chi, et al.
Publicado: (2018)

Frontotemporal dementia to Alzheimer's disease
por: Silveri, Maria Caterina
Publicado: (2007)

Frontal variant of Alzheimer's disease with asymmetric presentation mimicking frontotemporal dementia: Case report and literature review
por: Li, Cheng‐Hsuan, et al.
Publicado: (2020)

Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson’s Disease
por: Lin, Chin-Hsien, et al.
Publicado: (2019)

Synuclein Motor Dysfunction Composite Scale for the Discrimination of Dementia With Lewy Bodies From Alzheimer’s Disease
por: Chen, Ying-Tsung, et al.
Publicado: (2022)

Neuropsychiatric Symptoms and Caregiver Stress in Parkinson’s Disease with Cognitive Impairment, Alzheimer’s Disease, and Frontotemporal Dementia
por: Chang, Yu-Tzu, et al.
Publicado: (2023)

Assessment of High Risk for Alzheimer’s Disease Using Plasma Biomarkers in Subjects with Normal Cognition in Taiwan: A Preliminary Study
por: Hu, Chaur-Jong, et al.
Publicado: (2021)

Presenilins in Alzheimer’s disease and frontotemporal dementia
por: Shen, Jie
Publicado: (2012)

Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer’s Disease
por: Yang, Shieh-Yueh, et al.
Publicado: (2017)

Cortical function in Alzheimer’s disease and frontotemporal dementia
por: Wang, Pan, et al.
Publicado: (2016)

Working Memory in Alzheimer’s Disease and Frontotemporal Dementia
por: Stopford, C. L., et al.
Publicado: (2010)

Plasma Extracellular Vesicle Size and Concentration Are Altered in Alzheimer’s Disease, Dementia With Lewy Bodies, and Frontotemporal Dementia
por: Longobardi, Antonio, et al.
Publicado: (2021)

Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer’s Disease and Frontotemporal Dementia
por: Álvarez-Sánchez, Lourdes, et al.
Publicado: (2023)

Apolipoprotein D Upregulation in Alzheimer’s Disease but Not Frontotemporal Dementia
por: Bhatia, Surabhi, et al.
Publicado: (2018)

Distinctive Oculomotor Behaviors in Alzheimer's Disease and Frontotemporal Dementia
por: Lage, Carmen, et al.
Publicado: (2021)

CYLD variants identified in Alzheimer's disease and frontotemporal dementia patients
por: Xiao, Xuewen, et al.
Publicado: (2022)

Evidence of plasma biomarkers indicating high risk of dementia in cognitively normal subjects
por: Pai, Ming-Chyi, et al.
Publicado: (2022)

Neuropsychiatric Symptoms in Parkinson’s Disease Dementia Are More Similar to Alzheimer’s Disease than Dementia with Lewy Bodies: A Case-Control Study
por: Chiu, Pai-Yi, et al.
Publicado: (2016)

Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts
por: Lue, Lih-Fen, et al.
Publicado: (2017)

Biomarkers for the diagnosis of Alzheimer’s disease, dementia Lewy body, frontotemporal dementia and vascular dementia
por: Maclin, Joshua Marvin Anthony, et al.
Publicado: (2019)

Animal models for Alzheimer's disease and frontotemporal dementia: a perspective
por: Götz, Jürgen, et al.
Publicado: (2009)

Mutational analysis of PRNP in Alzheimer’s disease and frontotemporal dementia in China
por: Zhang, Weiwei, et al.
Publicado: (2016)

Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia
por: Marino, Silvia, et al.
Publicado: (2019)

An MRI-based strategy for differentiation of frontotemporal dementia and Alzheimer’s disease
por: Yu, Qun, et al.
Publicado: (2021)

Episodic Memory in Amnestic Behavioral Frontotemporal Dementia and Alzheimer’s Disease
por: Bussè, Cinzia, et al.
Publicado: (2023)

Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy
por: Chouliaras, Leonidas, et al.
Publicado: (2022)

Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease
por: Chang, Chun-Wei, et al.
Publicado: (2020)

Visual hallucinations in Alzheimer's disease is significantly associated with clinical diagnostic features of dementia with Lewy bodies
por: Chiu, Pai-Yi, et al.
Publicado: (2017)

Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology
por: Liu, Huei-Chun, et al.
Publicado: (2020)

Investigation of the Number of Tests Required for Assaying Plasma Biomarkers Associated with Alzheimer’s Disease Using Immunomagnetic Reduction
por: Liu, Huei-Chun, et al.
Publicado: (2021)

Usefulness of EEG Techniques in Distinguishing Frontotemporal Dementia from Alzheimer's Disease and Other Dementias
por: Nardone, Raffaele, et al.
Publicado: (2018)

Amnesia in Frontotemporal Dementia with Amyotrophic Lateral Sclerosis, Masquerading Alzheimer's Disease
por: Yamanami-Irioka, A., et al.
Publicado: (2011)

Longitudinal Grey and White Matter Changes in Frontotemporal Dementia and Alzheimer’s Disease
por: Frings, Lars, et al.
Publicado: (2014)

The pathogenesis of cingulate atrophy in behavioral variant frontotemporal dementia and Alzheimer’s disease
por: Tan, Rachel H, et al.
Publicado: (2013)

Fronto-Striatal Atrophy in Behavioral Variant Frontotemporal Dementia and Alzheimer’s Disease
por: Bertoux, Maxime, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_62jtsl9li2cp6cv7fetcbse4mm